PFS increase but no OS increase for niraparib in advanced ovarian cancer
PFS increase but no OS increase for niraparib in advanced ovarian cancer
Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and testicular cancers
Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancer
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies
Assessment of suicide risk in cancer patients
Association of adult attachment with delays in accessing specialist care in women with ovarian cancer
Cancer journeys: Research from India
Depression in cancer
Managing 'fear of recurrence' of cancer patients
Psychological issues in familial cancer
Cancer advocacy and fundraising in Nigeria
Atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy in recurrent ovarian cancer